Ovarian Cancer
DNA microarray expression profiling predicts chemotherapeutic response
Published in Cancer Weekly, December 21st, 2004
"Despite treatment, a large number of women with ovarian cancer eventually relapse and die of [ovarian cancer]. Hence, recurrent ovarian cancer continues to be a therapeutic dilemma, possibly a result of the emergence of drug resistance during relapse," said Z.E. Selvanayagam and colleagues, University of Hong Kong, Prince of Wales Hospital.
"Recent advances in expression genomics enable global transcript analysis that leads to molecular classification of cancers and prediction of outcome and treatment response," they...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2004-12-21)
More Articles from Cancer Weekly
- Acute Lymphoblastic Leukemia
Busulfan good alternative to TBI to improve quality of life in childhood ALL - Acute Promyelocytic Leukemia
Novel immunoassay provides rapid and accurate APL diagnosis - Lymphoma
Simian virus 40 not involved in lymphoma pathogenesis - Non-Hodgkin Lymphoma
Cancer risk appears lower with multiple pregnancies, higher with later menarche - Accreditation
Hospital achieves gold seal and disease specific certification from JCAHO - Acute Lymphoblastic Leukemia
DLI successfully treats hematological/extramedullary relapse of MLL-positive ALL - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
